A new Canadian Cancer Trials Group (CCTG) survey study, SC32S, has opened across Canada to collect sociodemographic data from cancer clinical trial participants and assess whether asking questions about this information feels appropriate to patients. The patient survey will ask CCTG trial participants about different parts of everyday life that can affect patient health and experience with cancer care.
Congratulations to Ecaterina (Cathy) Cozma from the Stirling lab (Terry Fox Laboratory) on receiving the Canada Graduate Research Scholarship – Doctoral (CGRS D) program for her project, “Characterizing DNA repair deficient cancers benefiting from polymerase Z inhibition.”
Summer research studentships, sponsored by the BC Cancer Foundation, support senior undergraduate university students and/or junior medical or dental students seeking hands-on training in cancer research in British Columbia. These studentships may address any discipline of cancer research including clinical, translational, basic, behavioral and population health.
Congratulations to this year’s recipients and their supervisors!
Read the Canadian Cancer Trials Group story on results from a pre-planned secondary analysis of the PR21 PLUDO trial.
Three BC Cancer clinical investigators are participating in the Canadian Cancer Trials Group (CCTG) VISION – Investigator Leadership Training Program, a new education and mentorship initiative focused on developing leadership skills among current and emerging clinical trialists.
Drs. Leah Lambert, Jonathan Loree and Lucia Nappi are part of the inaugural VISION cohort.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.